Physician profile
Jadie De Tolla
NPI 1184043366
$4,605.36
in general payments reported to CMS, 2019-2025
11 companies · $328 in 2025
The $328 reported for 2025 was more than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $2,668 · 2021: $178 · 2022: $624 · 2023: $311 · 2024: $497 · 2025: $328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,136.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,135.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gotham Surgical Solutions & Devices, INC. | $1,702.23 | 2020-2022 | |
| Medartis INC. | $1,318.89 | 2020-2024 | Aptus |
| Acumed LLC | $498.58 | 2022-2025 | Acumed, Acumed, Inframe Implant |
| Stryker Corporation | $280.19 | 2021-2022 | |
| Skeletal Dynamics INC | $255.97 | 2023-2024 | Align, Implate, Geminus |
| Depuy Synthes Sales INC. | $201.64 | 2022-2025 | Na |
| Endo Pharmaceuticals INC. | $184.68 | 2021-2024 | Xiaflex |
| Endo USA, INC. | $74.04 | 2024-2025 | Xiaflex |
| Orthofix Medical, INC. | $34.84 | 2025 | Physio-Stim |
| Suvon Surgical LLC | $29.46 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $24.84 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jadie De Tolla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.